BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Manzia TM, Parente A, Lenci I, Sensi B, Milana M, Gazia C, Signorello A, Angelico R, Grassi G, Tisone G, Baiocchi L. Moving forward in the treatment of cholangiocarcinoma. World J Gastrointest Oncol 2021; 13(12): 1939-1955 [PMID: 35070034 DOI: 10.4251/wjgo.v13.i12.1939]
URL: https://www.wjgnet.com/1948-5204/full/v13/i12/1939.htm
Number Citing Articles
1
Jihye L. Golino, Xin Wang, Hoyoung M. Maeng, Changqing Xie. Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell TranscriptomicsCells 2023; 12(6): 862 doi: 10.3390/cells12060862
2
Wen-Jie Ma, Zheng-Hua Li, Zhen-Ru Wu, Fei Liu, Jun-Ke Wang, Yu-Jun Shi, Yan-Wen Jin, Fu-Yu Li. PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancersNeoplasia 2023; 43: 100920 doi: 10.1016/j.neo.2023.100920
3
Juli Busquets, Luís Secanella, Paula Cifre, María Sorribas, Teresa Serrano, Laura Martínez-Carnicero, David Leiva, Berta Laquente, Silvia Salord, Nuria Peláez, Juan Fabregat. Prognostic risk factors in 113 patients undergoing cephalic duodenopancreatectomy for distal cholangiocarcinomaGastroenterología y Hepatología (English Edition) 2024; 47(5): 448 doi: 10.1016/j.gastre.2024.04.004
4
Juli Busquets, Luís Secanella, Paula Cifre, María Sorribas, Teresa Serrano, Laura Martínez-Carnicero, David Leiva, Berta Laquente, Silvia Salord, Nuria Peláez, Juan Fabregat. Factores de mal pronóstico en 113 pacientes sometidos a duodenopancreatectomía cefálica por colangiocarcinoma distalGastroenterología y Hepatología 2024; 47(5): 448 doi: 10.1016/j.gastrohep.2023.09.009